Review





Similar Products

gene exp c1qc hs00757779 m1  (Thermo Fisher)
89
Thermo Fisher gene exp c1qc hs00757779 m1
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
Gene Exp C1qc Hs00757779 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pmc13112662-74-18-12?v=Thermo+Fisher
Average 89 stars, based on 1 article reviews
gene exp c1qc hs00757779 m1 - by Bioz Stars, 2026-07
89/100 stars
  Buy from Supplier
antic1qc c1qg hrp polyclonal antibody  (Bioss)
94
Bioss antic1qc c1qg hrp polyclonal antibody
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
Antic1qc C1qg Hrp Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pm41820911-312-6-11?v=Bioss
Average 94 stars, based on 1 article reviews
antic1qc c1qg hrp polyclonal antibody - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
c1qc  (Proteintech)
93
Proteintech c1qc
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
C1qc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pm41862467-510-12-13?v=Proteintech
Average 93 stars, based on 1 article reviews
c1qc - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
anti c1qc c1qg hrp polyclonal antibody  (Bioss)
94
Bioss anti c1qc c1qg hrp polyclonal antibody
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
Anti C1qc C1qg Hrp Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pmc13097705-296-6-11?v=Bioss
Average 94 stars, based on 1 article reviews
anti c1qc c1qg hrp polyclonal antibody - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
c1qc  (Galectin Therapeutics)
86
Galectin Therapeutics c1qc
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
C1qc, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pm41787508-185-7-11?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
c1qc - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
anti c1qc  (Proteintech)
93
Proteintech anti c1qc
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
Anti C1qc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pmc12992019-110-18-21?v=Proteintech
Average 93 stars, based on 1 article reviews
anti c1qc - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
anti c1qa  (Proteintech)
93
Proteintech anti c1qa
Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of <t>C1QC</t> and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange
Anti C1qa, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c1qc/pmc12854232-61-33-34?v=Proteintech
Average 93 stars, based on 1 article reviews
anti c1qa - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of C1QC and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange

Journal: Acta Neuropathologica Communications

Article Title: Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravis

doi: 10.1186/s40478-026-02284-0

Figure Lengend Snippet: Complement deposition at NMJ and gene expression of complement factors. a Enzyme histochemical preparation by non-specific esterase shows motor endpoint regions with terminal nerve bundles (asterisk) and neuromuscular junctions (NMJ, white arrows) in LRP4-ab + and AChR-ab+-MG patients as well as non-diseased controls (NDC). Only in myasthenia gravis (MG) patients, NMJ are stained positive for C5b-9. Note, physiological positivity of small arterioles (with a lumen) in NDC muscle tissues, while endplates are not stained. b Counting of C5b-9 positive endplates in the whole slide demonstrated a range of 6–96% and a mean of 46% C5b-9 + endplates in LRP4-ab + MG patients (double positive patients marked in orange), while in AChR+ patients, range was 33–100% with a mean of 75%. c Gene transcript analyses of complement factors via qPCR demonstrated increased expression of C1QC and C3 in MG patients without reaching statistical significance. Statistics with Ordinary one-way ANOVA with Tukey´s multiple comparison test or Mann-Whitney U test, p < 0.05. LRP4/AChR-double positive patients marked in orange

Article Snippet: The qPCR assay identification numbers, TaqMan ® Gene Exp Assay from Life Technologies/ThermoFisher are listed as follows: C1QC Hs00757779_m1, C3 Hs00163811_m1, C5 Hs01004342_m1, PGK1 Hs99999906_m1.

Techniques: Gene Expression, Staining, Expressing, Comparison, MANN-WHITNEY